Showing results (251-260 of 279) with videos related to
Sort By:
Pageof 28
Immunology|January 1, 1984
Role of C3 in the control of monocyte C2 productionA O Hamilton, L Morrison, W S Kilpatrick, et al.Comprehensive Reviews in Food Science and Food Safety|June 29, 2022
Heat- and shear-reversible networks in food: A reviewArkaye V Kierulf, Judith K Whaley, Weichang Liu, et al.Tissue Antigens|February 1, 1975
The association between HL-A antigens ankylosing spondylitis and sacro-iliitisH M Dick, R D Sturrock, G K Goel, et al.The Journal of Rheumatology|November 1, 1991
Ankylosing spondylitis antirheumatic drug trials. II. Tables for calculating sample size for clinical trialsN Bellamy, W W Buchanan, J M Esdaile, et al.The Journal of Rheumatology|November 1, 1991
Ankylosing spondylitis antirheumatic drug trials. III. Setting the delta for clinical trials of antirheumatic drugs--results of a consensus development (Delphi) exerciseN Bellamy, W W Buchanan, J M Esdaile, et al.The Journal of Rheumatology|November 1, 1991
Ankylosing spondylitis antirheumatic drug trials. I. Effects of standardization procedures on observer dependent outcome measuresN Bellamy, W W Buchanan, J M Esdaile, et al.The Journal of Rheumatology|December 1, 1987
Low dose cyclosporine in rheumatoid arthritis: a pilot studyP Tugwell, C Bombardier, M Gent, et al.The Journal of Rheumatology|November 1, 1994
A comparative study of signal versus aggregate methods of outcome measurement based on the WOMAC Osteoarthritis Index. Western Ontario and McMaster Universities Osteoarthritis IndexS Barr, N Bellamy, W W Buchanan, et al.Immunobiology|July 1, 1993
Human complement factor B: functional properties of a recombinant zymogen of the alternative activation pathway convertaseW Schwaeble, B Lüttig, T Sokolowski, et al.European Journal of Clinical Investigation|February 1, 1989
Monocyte C1-inhibitor synthesis in patients with C1-inhibitor deficiencyD F Lappin, A R McPhaden, P L Yap, et al.Pageof 28